Semaglutide belongs to a broader class of medications known as GLP-1 receptor agonists, which are used to treat obesity and type 2 diabetes. Semaglutides act like the glucagon-like peptide-1 (GLP-1) hormone our bodies make, which is released from our gut after we eat, explains Jessica Duncan, MD, DABOM, DABA, chief medical officer at Ivim Health
Diabetes 62:11311138 Cegla J, Troke RC, Jones B et al (2014) Coinfusion of low-dose GLP-1 and glucagon in man results in a reduction in food intake
Key Facts The FDA received an unspecified number of reports of dosing errors involving compounded semaglutidethe active ingredient in Ozempic and Wegovyfrom patients prescribed the drug, including some who required medical attention or hospitalization, according to the agency
This is one reason why researchers interested in microdosing often reconstitute with more water (3mL or even 4mL) to get a lower concentration that makes small doses easier to measure
Instead, it depends on targeted symptom assessment and risk stratification
Direct Food Associations PFAS arises due to cross-reactivity